These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9150904)

  • 1. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice.
    Hambly RJ; Double JA; Thompson MJ; Bibby MC
    Breast Cancer Res Treat; 1997 May; 43(3):247-58. PubMed ID: 9150904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of three new breast-cancer cell lines.
    Siwek B; Larsimont D; Lacroix M; Body JJ
    Int J Cancer; 1998 May; 76(5):677-83. PubMed ID: 9610725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin.
    Möbus VJ; Moll R; Gerharz CD; Kieback DG; Merk O; Runnebaum IB; Linner S; Dreher L; Grill HJ; Kreienberg R
    Int J Cancer; 1998 Jul; 77(3):415-23. PubMed ID: 9663605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological differences among MCF-7 human breast cancer cell lines from different laboratories.
    Osborne CK; Hobbs K; Trent JM
    Breast Cancer Res Treat; 1987; 9(2):111-21. PubMed ID: 3620713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of a new cell line derived from a human primary breast carcinoma.
    Wang CS; Goulet F; Lavoie J; Drouin R; Auger F; Champetier S; Germain L; Têtu B
    Cancer Genet Cytogenet; 2000 Jul; 120(1):58-72. PubMed ID: 10913678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.
    Kurebayashi J; Kurosumi M; Sonoo H
    Br J Cancer; 1995 Apr; 71(4):845-53. PubMed ID: 7710953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.
    Shenhua X; Lijuan Q; Hanzhou N; Xinghao N; Chihong Z; Gu Z; Weifang D; Yongliang G
    J Exp Clin Cancer Res; 1999 Jun; 18(2):233-9. PubMed ID: 10464713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma.
    Gioanni J; Le François D; Zanghellini E; Mazeau C; Ettore F; Lambert JC; Schneider M; Dutrillaux B
    Br J Cancer; 1990 Jul; 62(1):8-13. PubMed ID: 2390488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the T61 human breast carcinoma established in nude mice.
    Brünner N; Bastert GB; Poulsen HS; Spang-Thomsen M; Engelholm SA; Vindeløv L; Nielsen A; Tommerup N; Elling F
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):833-43. PubMed ID: 4043171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.
    Mehta RR; Bratescu L; Graves JM; Hart GD; Shilkaitis A; Green A; Beattie CW; Das Gupta TK
    Anticancer Res; 1992; 12(3):683-92. PubMed ID: 1377894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6.
    Kurebayashi J; Otsuki T; Tang CK; Kurosumi M; Yamamoto S; Tanaka K; Mochizuki M; Nakamura H; Sonoo H
    Br J Cancer; 1999 Feb; 79(5-6):707-17. PubMed ID: 10070858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.
    Prévost G; Lanson M; Thomas F; Veber N; Gonzalez W; Beaupain R; Starzec A; Bogden A
    Cancer Res; 1992 Feb; 52(4):843-50. PubMed ID: 1346585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
    Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonally related but phenotypically divergent human cancer cell lines derived from a single follicular thyroid cancer recurrence (TT2609).
    Geldof AA; Versteegh LRT ; van Mourik JC; Rooimans MA; Arwert F; Hermsen MA; Schadee-Eestermans IL; van Dongen GA; van der Valk P; van der Clement EHP ; Lips P; Teule GJ
    Thyroid; 2001 Oct; 11(10):909-17. PubMed ID: 11716037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of breast carcinoma cell lines as in vitro and in vivo models for breast cancer diagnosis and therapy.
    Ceriani RL; Peterson JA; Blank EW; Chan CM; Cailleau R
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):397-402. PubMed ID: 1634439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.